课题基金 / 基金详情

BEHAVIORAL EFFECTS AND ABUSE OF DRUGS: ANTIHISTAMINES

BEHAVIORAL EFFECTS AND ABUSE OF DRUGS: ANTIHISTAMINES
行为影响和药物滥用:抗组胺药
批准号:
3208402
负责人:
JACK BERGMAN
金额:
$15.81万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1985
资助国家:
美国
项目状态:
已结题
起止时间:
1985-08-01 至 1990-07-31

项目摘要

项目成果

JACK BERGMAN的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Histamine H1 antagonists are among the most frequently used drugs in contemporary society and are abused in combination with opioids by certain drug-dependent populations. Our previous work has shown that prototypical H1 antagonists have striking effects on schedule-controlled behavior that can be attenuated by the dopamine antagonist haloperidol. One major focus of the proposed research is to evaluate further the role of dopamine- related actions in the behavioral effects of H1 antagonists by: 1) comparing the effects of H1 antagonists with those of selective D1 and D2 agonists and 2) studying how the behavioral effects of H1 antagonists are altered by selective D1 and D2 antagonists. We previously have found that selected H1 antagonists can maintain persistent drug-taking behavior in squirrel monkeys. A second focus of this project is to extend these findings by: 1) studying the development of self-administration in drug-naive subjects, 2) evaluating the effects of self-administered H1 antagonists on other ongoing behavior, and 3) investigating how the reinforcing effects of H1 antagonists are modified by dopamine D1 and D2 antagonists. Our ongoing research indicates that H1 antagonists can potentiate the behavioral effects of cocaine and caffeine. A third focus of the proposed research is to extend these studies by systematically determining how H1 antagonists modify the reinforcing and other behavioral effects of cocaine, caffeine, and nicotine. The final objective of the proposed research is to continue our evaluation of the behavioral effects of opioids alone and in combination with histamine H1 antagonists. We will assess interactions between these drug classes by determining how H1 antagonists modify the reinforcing and other behavioral effects of pentazocine and other opioids. Overall, the proposed research will provide needed information about pharmacological and environmental factors mediating the behavioral effects of histamine H1 antagonists alone and in combination with other commonly used drugs.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
In vivo characterization of opioid biased agonists
  • 批准号:
    10062935
  • 项目类别:
  • 资助金额:
    $24.56万
  • 财政年份:
    2019
  • 负责人:
    JACK BERGMAN
  • 依托单位:
Neural, Cognitive and Abuse-Related Consequences of Chronic THC Exposure during Adolescence in Nonhuman Primates
  • 批准号:
    10609878
  • 项目类别:
  • 资助金额:
    $55.63万
  • 财政年份:
    2019
  • 负责人:
    JACK BERGMAN
  • 依托单位:
Neural, Cognitive and Abuse-Related Consequences of Chronic THC Exposure during Adolescence in Nonhuman Primates
  • 批准号:
    10399441
  • 项目类别:
  • 资助金额:
    $71.84万
  • 财政年份:
    2019
  • 负责人:
    JACK BERGMAN
  • 依托单位:
Neural, Cognitive and Abuse-Related Consequences of Chronic THC Exposure during Adolescence in Nonhuman Primates
  • 批准号:
    10152566
  • 项目类别:
  • 资助金额:
    $71.9万
  • 财政年份:
    2019
  • 负责人:
    JACK BERGMAN
  • 依托单位:
海外基金